Volunteers sought for IU School of Medicine diabetes research study
INDIANPOLIS — Indiana University School of Medicine is one of 37 sites selected by the National Institutes of Health for a study of the long-term risks and benefits of four widely used diabetes drugs used in combination with metformin, the most common first-line medication for treating type 2 diabetes.
Participants enrolling in GRADE, or the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study, will take metformin, along with a second medication randomly assigned from among four classes of medications approved for use with metformin by the U.S. Food and Drug Administration. All study medications will be provided free of charge.
For additional information or to enroll in the study at IU, contact the GRADE study coordinator at 317-274-7679 or firstname.lastname@example.org.